Dr. Konstantinos Tziomalos
Aristotle University of Thessaloniki, Greece
Email: ktziomalos@yahoo.com
Qualifications
2007 Ph.D., Aristotle University of Thessaloniki, Greece
2003 M.Sc., Aristotle University of Thessaloniki, Greece
1998 B.Sc., Aristotle University of Thessaloniki, Greece
Publications
-
Koiou E, Tziomalos K, Katsikis I, Kandaraki
EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D. Weight loss significantly
reduces serum lipocalin-2 levels in overweight and obese women with polycystic
ovary syndrome. Gynecol Endocrinol 2011 Jul 14.
-
Athyros VG, Karagiannis
A, Ganotakis E, Paletas K, Nicolaou V, Bacharoudis G, Tziomalos K, Alexandrides
T, Elisaf MS, Mikhailidis DP; for the Assessing The Treatment Effect in
Metabolic syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group.
Association between the changes in renal function and serum uric acid levels
during multifactorial intervention and clinical outcome in patients with
metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin
2011; 27: 1659-1668.
-
Pagourelias ED, Gossios
TD, Tziomalos K, Karagiannis A, Geleris P, Athyros VG. Residual cardiac risk reduction
beyond lipid lowering. Hellenic J Cardiol 2011; 52: 197-203.
-
Koiou E, Dinas K, Tziomalos K, Toulis K,
Kandaraki EA, Kalaitzakis E, Katsikis I, Panidis D. The phenotypes of
polycystic ovary syndrome defined by the 1990 diagnostic criteria are
associated with higher serum vaspin levels than the phenotypes introduced by
the 2003 criteria. Obes Facts 2011; 4: 145-150.
-
Katsinelos P, Tziomalos
K, Fasoulas K, Paroutoglou G, Koufokotsios A, Mimidis K, Terzoudis S, Maris T,
Beltsis A, Geros C, Chatzimavroudis G. Can capsule endoscopy be used as a
diagnostic tool in the evaluation of non-bleeding indications in daily clinical
practice? A prospective study. Medical Principles and Practice 2011; 20:
362-367.
-
Koiou E, Tziomalos K, Katsikis I, Kalaitzakis
E, Kandaraki EA, Tsourdi EA, Delkos D, Papadakis E, Panidis D. Circulating platelet-derived
microparticles are elevated in women with polycystic ovary syndrome diagnosed
with the 1990 criteria and correlate with serum testosterone levels. Eur J
Endocrinol 2011; 165: 63-68.
-
Athyros VG, Ganotakis E, Kolovou GD, Nicolaou
V, Achimastos A, Bilianou E, Alexandrides T, Karagiannis A, Paletas K,
Liberopoulos EN, Tziomalos K, Petridis D, Kakafika A, Elisaf MS, Mikhailidis
DP; for the Assessing The Treatment Effect in Metabolic Syndrome Without
Perceptible Diabetes (ATTEMPT) Collaborative. Assessing The Treatment Effect in
Metabolic Syndrome without Perceptible Diabetes (ATTEMPT): A
Prospective-Randomized Study in Middle Aged Men and Women. Curr Vasc Pharmacol
2011 Apr 11.
-
Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for
cardiovascular risk and non alcoholic fatty liver disease. Killing two birds
with one stone? Ann Med 2011; 43: 167-171.
-
Athyros VG, Karagiannis A, Tziomalos K, Gossios TD, Mikhailidis DP. Raised liver enzymes in patients
taking statins. Lancet
2011; 377: 1075-1076.
-
Athyros VG, Tziomalos K,
Karagiannis A, Mikhailidis DP. Dyslipidaemia of obesity, metabolic
syndrome and type 2 diabetes mellitus: the case for residual risk reduction
after statin treatment. Open Cardiovasc Med J 2011; 5: 24-34.
-
Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Dyslipidemia induced by drugs
used for the prevention and treatment of vascular diseases. Open Cardiovasc Med
J 2011; 5: 85-89.
-
Tsantilas D, Hatzitolios AI, Tziomalos K,
Karamitsos D, Papadimitriou D. The effects of buflomedil on skin blood flow in patients with type 2
diabetes mellitus without overt micro- or macroangiopathy. Int Angiol 2011; 30: 164-171.
-
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Cardiovascular benefits of
bariatric surgery in morbidly obese patients. Obes Rev 2011; 12: 515-524.
-
Koiou E, Tziomalos K, Dinas K, Katsikis I,
Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D. The effect of weight loss and
treatment with metformin on serum vaspin levels in women with polycystic ovary
syndrome. Endocr J 2011; 58: 237-246.
-
Panidis D, Tziomalos K, Koiou E, Kandaraki
EA, Tsourdi E, Delkos D, Kalaitzakis E, Katsikis I. The effects of obesity and
polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study. Reprod
Biol Endocrinol 2010; 8: 151.
-
Stavrinou E, Koumaras C, Gossios TD, Tziomalos K, Athyros VG, Karagiannis A. Atherosclerotic renal artery stenosis: an update on diagnosis
and management. Curr Vasc Pharmacol 2010 Dec 14. [Epub ahead of print].
-
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Preventing type 2 diabetes
mellitus: room for residual risk reduction after lifestyle changes? Curr Pharm Des 2010; 16: 3839-3847.
-
Athyros VG, Tziomalos K,
Gossios TD, Griva T, Anagnostis P, Kargiotis K, Pagourelias ED, Theocharidou E,
Karagiannis A, Mikhailidis DP; for the GREACE Study Collaborative Group. Safety and
efficacy of long-term statin treatment for cardiovascular events in patients
with coronary heart disease and abnormal liver tests in the Greek Atorvastatin
and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
Lancet 2010; 376: 1916-1922.
-
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. To switch (statins) or not to switch?
That is the question. Expert Opin Pharmacother 2010; 11: 2943-2946.
-
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Statin-fibrate combination
for mixed dyslipidaemia: a limited option? Curr Med Res Opin 2010; 26:
2137-2140.